# Definium Therapeutics, Inc.: Form 8-K, filed Aug 26, 2022

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2022-08-26
- Accepted by EDGAR: Aug 26, 2022, 16:45 ET
- Period: 2022-08-26
- Accession: 0001193125-22-231372
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000119312522231372/d384325d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000119312522231372/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000119312522231372/d384325d8k.htm

Filed Aug 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-231372. Last ingested by Listed: Nov 5, 2026, 13:55 ET. No prices; not investment advice.